Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.34 | - |
NAV | ₹19.37 | - |
Fund Started | 17 Dec 2018 | - |
Fund Size | ₹47.53 Cr | - |
Exit Load | - | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -7.28% | - |
3 Year | 8.41% | - |
5 Year | 11.36% | - |
1 Year
3 Year
5 Year
Equity | 96.16% | - |
Cash | 1.73% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 4.26% |
The Indian Hotels Company Ltd. | 3.93% |
Bharti Airtel Ltd. | 3.70% |
Dixon Technologies (India) Ltd. | 3.02% |
Divi's Laboratories Ltd. | 2.94% |
ICICI Bank Ltd. | 2.93% |
Lupin Ltd. | 2.93% |
Mahindra & Mahindra Ltd. | 2.89% |
Apollo Hospitals Enterprise Ltd. | 2.72% |
Trent Ltd. | 2.64% |
Name | Gargi Bhattacharyya Banerjee | - |
Start Date | 21 Nov 2019 | - |
Name
Start Date
Description | The Scheme seeks to generate income and long-term capital appreciation from a diversified portfolio of predominantly equity and equity related securities and enable investors to avail the income tax rebate, as permitted from time to time. | - |
Launch Date | 17 Dec 2018 | - |
Description
Launch Date